BOXER CAPITAL
Boxer Capital caters to public companies based in the biotechnology industry.
BOXER CAPITAL
Industry:
Biotechnology Venture Capital
Founded:
2005-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-07 | SpringWorks Therapeutics | Boxer Capital investment in Post-IPO Equity - SpringWorks Therapeutics | 225 M USD |
| 2022-07-13 | Gossamer Bio | Boxer Capital investment in Post-IPO Equity - Gossamer Bio | 120 M USD |
| 2022-03-31 | Incyclix Bio | Boxer Capital investment in Series B - Incyclix Bio | 30 M USD |
| 2022-03-16 | 2seventy bio | Boxer Capital investment in Post-IPO Equity - 2seventy bio | 170 M USD |
| 2022-02-09 | Seismic Therapeutic | Boxer Capital investment in Series A - Seismic Therapeutic | 101 M USD |
| 2022-01-19 | Alterome Therapeutics | Boxer Capital investment in Series A - Alterome Therapeutics | 64 M USD |
| 2022-01-19 | Ceptur Therapeutics | Boxer Capital investment in Series A - Ceptur Therapeutics | 75 M USD |
| 2022-01-19 | Enliven Therapeutics | Boxer Capital investment in Series B - Enliven Therapeutics | 85 M USD |
| 2022-01-16 | Third Harmonic Bio | Boxer Capital investment in Series B - Third Harmonic Bio | 105 M USD |
| 2021-12-17 | EQRx | Boxer Capital investment in Post-IPO Equity - EQRx | 1.2 B USD |